Research graph
References from Transcriptionally distinct atypical B cell populations contribute to insulin autoreactivity and show differential activation, isotype switching, and somatic hypermutation in early-stage type 1 diabetes individuals. Local targets link to admitted publications; unresolved targets remain external evidence.
The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum
10.2337/dbi25-0011 · 2025 · External reference
Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine
10.1038/s41467-022-31142-5 · 2022 · External reference
10.2337/dc13-0626
10.2337/dc13-0626 · External reference
10.1056/nejmoa0904452
10.1056/nejmoa0904452 · External reference
10.2337/dc15-1419
10.2337/dc15-1419 · External reference
Dual-parameter model for prediction of type I diabetes mellitus
1998 · External reference
10.4049/jimmunol.167.10.5535
10.4049/jimmunol.167.10.5535 · External reference
10.4049/jimmunol.161.8.3912
10.4049/jimmunol.161.8.3912 · External reference
10.1002/1521-4141(200212)32:12<3657::aid-immu3657>3.0.co;2-e
10.1002/1521-4141(200212)32:12<3657::aid-immu3657>3.0.co;2-e · External reference
10.4049/jimmunol.163.2.743
10.4049/jimmunol.163.2.743 · External reference
10.1084/jem.184.5.2049
10.1084/jem.184.5.2049 · External reference
10.4049/jimmunol.1202104
10.4049/jimmunol.1202104 · External reference
10.1084/jem.20151869
10.1084/jem.20151869 · External reference
BCL6 in T cells promotes type 1 diabetes by redirecting fates of insulin-autoreactive B lymphocytes
10.1016/j.isci.2026.115990 · 2026 · External reference
10.1111/imr.70058
10.1111/imr.70058 · External reference
10.1016/jjmmuni.2025.08.007
10.1016/jjmmuni.2025.08.007 · External reference
10.3389/fimmu.2021.635615
10.3389/fimmu.2021.635615 · External reference
10.1016/j.immuni.2018.08.015
10.1016/j.immuni.2018.08.015 · External reference
CD21lo B-cell subsets are recruited to the central nervous system in acute neuromyelitis optica
10.1093/brain/awaf086 · 2025 · External reference
10.3389/fimmu.2023.1241474
10.3389/fimmu.2023.1241474 · External reference
10.1016/j.clim.2004.05.010
10.1016/j.clim.2004.05.010 · External reference
10.1007/s10238-021-00745-5
10.1007/s10238-021-00745-5 · External reference
10.1084/jem.20221346
10.1084/jem.20221346 · External reference
10.2337/db13-1798
10.2337/db13-1798 · External reference
10.3389/fimmu.2021.685718
10.3389/fimmu.2021.685718 · External reference
10.1084/jem.20221604
10.1084/jem.20221604 · External reference
10.1093/immhor/vlaf053
10.1093/immhor/vlaf053 · External reference
10.2337/dc10-2088
10.2337/dc10-2088 · External reference
10.1038/nature03523
10.1038/nature03523 · External reference
10.1073/pnas.040556697
10.1073/pnas.040556697 · External reference
10.4049/jimmunol.1701717
10.4049/jimmunol.1701717 · External reference
10.1016/j.jbi.2008.08.010
10.1016/j.jbi.2008.08.010 · External reference
10.1093/bioinformatics/btv359
10.1093/bioinformatics/btv359 · External reference
10.1007/978-1-61779-842-9_32
10.1007/978-1-61779-842-9_32 · External reference
10.1016/j.immuni.2020.06.013
10.1016/j.immuni.2020.06.013 · External reference
10.3389/fimmu.2021.602539
10.3389/fimmu.2021.602539 · External reference
10.1126/sciadv.abg8384
10.1126/sciadv.abg8384 · External reference
10.1172/jci.insight.155199
10.1172/jci.insight.155199 · External reference
10.4049/jimmunol.178.10.6624
10.4049/jimmunol.178.10.6624 · External reference
10.1091/mbc.e20-08-0532
10.1091/mbc.e20-08-0532 · External reference
10.1126/science.adf8531
10.1126/science.adf8531 · External reference
10.4049/jimmunol.178.5.2996
10.4049/jimmunol.178.5.2996 · External reference
10.1016/j.molimm.2011.09.008
10.1016/j.molimm.2011.09.008 · External reference
10.1038/ni.3642
10.1038/ni.3642 · External reference
10.1016/j.molcel.2021.07.037
10.1016/j.molcel.2021.07.037 · External reference
10.3389/fimmu.2014.00520
10.3389/fimmu.2014.00520 · External reference
10.1126/sciadv.ade8928
10.1126/sciadv.ade8928 · External reference
10.1016/j.immuni.2020.11.006
10.1016/j.immuni.2020.11.006 · External reference
10.4049/jimmunol.182.2.890
10.4049/jimmunol.182.2.890 · External reference
10.4049/jimmunol.170.2.686
10.4049/jimmunol.170.2.686 · External reference
10.4049/jimmunol.174.2.827
10.4049/jimmunol.174.2.827 · External reference
10.3389/fimmu.2023.1276014
10.3389/fimmu.2023.1276014 · External reference
Unresolved reference
External reference
10.1073/pnas.082114899
10.1073/pnas.082114899 · External reference
10.1016/j.cub.2003.09.034
10.1016/j.cub.2003.09.034 · External reference
10.1126/science.1086907
10.1126/science.1086907 · External reference
10.1111/j.1365-3083.1991.tb01574.x
10.1111/j.1365-3083.1991.tb01574.x · External reference
10.4049/jimmunol.172.7.4298
10.4049/jimmunol.172.7.4298 · External reference
VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics
1999 · External reference
10.1038/s41586-019-1595-3
10.1038/s41586-019-1595-3 · External reference
10.3389/fimmu.2026.1767837
10.3389/fimmu.2026.1767837 · External reference
10.1046/j.1365-2249.1998.00703.x
10.1046/j.1365-2249.1998.00703.x · External reference
Atypical B cells consist of subsets with distinct functional profiles
10.1016/j.isci.2023.108496 · 2023 · External reference
10.1016/j.celrep.2020.108684
10.1016/j.celrep.2020.108684 · External reference
10.1128/mcb.11.10.5197
10.1128/mcb.11.10.5197 · External reference
10.1101/gad.9.24.3067
10.1101/gad.9.24.3067 · External reference
Disease activity in systemic lupus erythematosus correlates with expression of the transcription factor AT-rich-interactive domain 3A
10.1002/art.38857 · 2014 · External reference
10.3389/fimmu.2019.02458
10.3389/fimmu.2019.02458 · External reference
10.3389/fimmu.2025.1608160
10.3389/fimmu.2025.1608160 · External reference
